StockNews.com Initiates Coverage on Ampio Pharmaceuticals (NYSE:AMPE)

Equities research analysts at StockNews.com began coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a research report issued on Saturday. The brokerage set a “sell” rating on the stock.

Ampio Pharmaceuticals Price Performance

Shares of Ampio Pharmaceuticals stock opened at $0.00 on Friday. The stock has a market capitalization of $2,383.50, a price-to-earnings ratio of 0.00 and a beta of 3.78. The business has a 50-day moving average of $0.01 and a 200 day moving average of $0.01. Ampio Pharmaceuticals has a 12 month low of $0.00 and a 12 month high of $1.99.

About Ampio Pharmaceuticals

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.